Mip Pharma Polska Sp. z o.o. operates as the Polish distribution and commercial platform of the MiP Pharma Group, supporting market access and supply to healthcare customers with a product focus aligned to the group portfolio. Business activity is centered on pharmaceutical distribution and sales/marketing execution, with emphasis on hospital-sector supply and selected specialist segments consistent with the group approach. The product footprint associated with the wider group includes hospital-relevant anti-infectives (including parenteral cephalosporins) and other prescription pharmaceuticals distributed via institutional and specialist channels, supported by local commercial operations. In Poland, the company is also associated with organizing medical conferences and training courses for physicians through a dedicated information and event platform, strengthening professional education touchpoints and stakeholder engagement. Geographic scope is Poland-focused with integration into the group network covering Germany, Poland and other Eastern European markets, alongside international sales reach in additional countries through the parent group. Key assets include affiliation with the MiP Pharma Group product and supply platform, a Poland-based commercial and distribution office, and a recurring physician-education/event capability supporting medical-community engagement. Strategic positioning focuses on dependable hospital and specialist-market supply of essential pharmaceuticals, leveraging group manufacturing/sourcing and portfolio strengths, and reinforcing market presence through structured sales/marketing and medical-education activities.
Headquarters
Ul. Orzechowa 5
Gdansk; Pomorskie;
Postal Code: 80-175
Contact Details: Purchase the Mip Pharma Polska Sp. z o.o. report to view the information.
Website: http://www.mip-pharma.pl
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service